BRIEF published on 06/17/2026 at 15:22, 2 months 26 days ago Vanguard Discloses Position in Schroders plc Form 8.3 Takeover Code Schroders Plc Vanguard Group Shareholding Disclosure
BRIEF published on 06/17/2026 at 15:20, 2 months 26 days ago The Vanguard Group Discloses Position in Forward Industries Form 8.3 Irish Takeover Panel The Vanguard Group Shareholding Disclosure Forward Industries Inc.
BRIEF published on 06/17/2026 at 15:18, 2 months 26 days ago The Vanguard Group, Inc. Discloses Significant Shareholding in Beazley plc Form 8.3 Takeover Code Vanguard Group Stakeholding Beazley Plc
PRESS RELEASE published on 06/17/2026 at 15:17, 2 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. discloses holding 2.57% stake in Schroders plc on 16 June 2026 per Form 8.3 under the Takeover Code Form 8.3 The Vanguard Group Takeover Code Schroders Plc Stake Disclosure
PRESS RELEASE published on 06/17/2026 at 15:15, 2 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Forward Industries Inc. The Vanguard Group, Inc. discloses a 2.11% interest in Forward Industries Inc. Ordinary Shares. No other parties involved. Dealings disclosed on 16 June 2026 Disclosure Vanguard Group Dealings Interests Forward Industries Inc.
PRESS RELEASE published on 06/17/2026 at 15:13, 2 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.02% ownership of Beazley plc's 5p ordinary securities. Dealings disclosed on 16 June 2026 Securities Dealings The Vanguard Group Ownership Disclosure Beazley Plc 5p Ordinary
BRIEF published on 06/16/2026 at 15:10, 2 months 27 days ago The Vanguard Group, Inc. Discloses Stake in Tate & Lyle plc Form 8.3 Takeover Code Vanguard Group Shareholding Disclosure Tate & Lyle
BRIEF published on 06/16/2026 at 15:07, 2 months 27 days ago The Vanguard Group Discloses Position in Spire Healthcare Group Form 8.3 Takeover Code Securities Disclosure Vanguard Group Spire Healthcare
PRESS RELEASE published on 06/16/2026 at 15:05, 2 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Tate & Lyle plc The Vanguard Group, Inc. discloses 4.74% stake in Tate & Lyle plc on 15 June 2026. Purchase of 92 securities at 5.67 GBP per unit disclosed The Vanguard Group, Inc. Stake Disclosure Securities Purchase Tate & Lyle Plc GBP 5.67
BRIEF published on 06/16/2026 at 15:03, 2 months 27 days ago The Vanguard Group Discloses Position in Schroders plc Takeover Code Schroders Plc Vanguard Group Stake Disclosure Equity Interests
Published on 09/12/2026 at 02:35, 1 day 18 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 22 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 2 days ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 2 days 4 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 1 day 3 hours ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 14 hours ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 23 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 23 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 2 days 1 hour ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 14 hours ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/10/2026 at 19:30, 3 days 2 hours ago Availability of the 2026 Interim Financial Report
